default author photo

Rinath Jeselsohn

Harvard University - Department of Medical Oncology, Dana-Farber Cancer Institute

SCHOLARLY PAPERS

2

DOWNLOADS

109

TOTAL CITATIONS

0

Scholarly Papers (2)

1.

Selective CDK7 Inhibition Has Dual Activity in Treatment Resistant Estrogen Receptor Positive Breast Cancer

Number of pages: 63 Posted: 20 Apr 2023
Harvard University - Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard University - Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard University - Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard University - Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard University - Department of Medical Oncology, Dana-Farber Cancer Institute, Massachusetts Institute of Technology (MIT) - Department of Biological Engineering, Harvard University - Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard University - Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard University - Department of Biomedical Informatics, Harvard University - Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard University - Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard University - Center for Functional Cancer Epigenetics, Harvard University - Department of Medical Oncology, Dana-Farber Cancer Institute, Baylor University - Lester and Sue Smith Breast Center, Azienda USL Toscana Centro - Bioinformatics Unit, Harvard University - Department of Oncologic Pathology, Harvard T.H. Chan School of Public Health - Department of Biostatistics, Baylor University - Department of Molecular and Cellular Biology, Harvard University - Lurie Family Imaging Center, Harvard University - Department of Oncologic Pathology, Azienda USL Toscana Centro - Sandro Pitigliani Translational Research Unit, Harvard University - Department of Cancer Biology, Harvard University - Department of Cancer Biology, Harvard University - Department of Data Science, Baylor University - Lester and Sue Smith Breast Center, Harvard University - Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard University - Department of Medical Oncology, Dana-Farber Cancer Institute and Independent
Downloads 79 (809,932)

Abstract:

Loading...

CDK7, breast cancer, ER positive, endocrine resistance, ESR1 mutant, CDK4/6 inhibitor resistance, Cell Cycle, CRISPR screen

2.

High FOXA1 Levels Induce ER Transcriptional Reprogramming and Promote a Pro-Metastatic Secretome and Metastasis in Endocrine-Resistant Breast Cancer

Number of pages: 87 Posted: 23 Nov 2021
Baylor College of Medicine, Baylor College of Medicine, Baylor College of Medicine, Baylor College of Medicine, Baylor College of Medicine, Baylor College of Medicine, Baylor College of Medicine, Baylor College of Medicine, Baylor College of Medicine, Baylor College of Medicine, Baylor College of Medicine, Baylor College of Medicine, Baylor College of Medicine, affiliation not provided to SSRN, University of Houston, affiliation not provided to SSRN, Harvard University - Dana-Farber Cancer Institute, Harvard University - Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard University - Department of Medical Oncology, Dana-Farber Cancer Institute, Baylor College of Medicine, Baylor College of Medicine and Baylor University - Lester and Sue Smith Breast Center
Downloads 30 (1,318,317)

Abstract:

Loading...

breast cancer, estrogen receptor, forkhead box protein A1, transcription factor, endocrine resistance, metastasis, secretome, transcriptional reprogramming, cistrome